DOSE FINDING STUDY OF PF-05212384 WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED SOLID TUMOR

Trial Profile

DOSE FINDING STUDY OF PF-05212384 WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED SOLID TUMOR

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Gedatolisib (Primary) ; Carboplatin; Paclitaxel
  • Indications Advanced breast cancer; Endometrial cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Mar 2017 Last checked against ClinicalTrials.gov record.
    • 24 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top